Cargando…
Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
BACKGROUND: The American Joint Committee on Cancer (AJCC) guideline recommends the evaluation of ≥10 axillary lymph nodes (ALN) in patients with breast cancer to assess the N stage. However, the total ALN count in ALN dissection (ALND) often decreases after neoadjuvant chemotherapy in breast cancer....
Autores principales: | Lee, Jeeyeon, Park, Nora Jee-Young, Kang, Byeongju, Jung, Jin Hyang, Kim, Wan Wook, Chae, Yee Soo, Lee, Soo Jung, Kim, Hye Jung, Park, Ji-Young, Park, Ho Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008405/ https://www.ncbi.nlm.nih.gov/pubmed/35433822 http://dx.doi.org/10.3389/fsurg.2022.678169 |
Ejemplares similares
-
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022) -
Vascularized Free Lymph Node Flap Transfer in Advanced Lymphedema Patient after Axillary Lymph Node Dissection
por: Cook, Kyung Hoon, et al.
Publicado: (2016) -
Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017) -
Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
por: Kim, Bong Kyun, et al.
Publicado: (2020) -
Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study
por: Kim, Won Hwa, et al.
Publicado: (2019)